Drug Shortage Across US Includes Epinephrine Syringes Used by Healthcare Providers


The US is experiencing critical drug shortages, mainly affecting generic medications that, according to a 2022 report by the Food and Drug Administration (FDA), comprise 91% of all prescriptions dispensed nationwide.

The shortage affects a wide range of drugs, including medications used to treat cancer, ADHD, RSV, and diabetes. There are currently over 300 drugs in short supply, a number that is increasing with time.

The two most significant reasons for the shortage are the unprecedented increase in demand and poor-quality manufacturing practices that have plagued the generics industry.

Click to visit sponsor

Here is a recent NBC News report detailing the problem:

The FDA currently lists two providers of prefilled 0.1mg/ml epinephrine syringes most often used in healthcare settings:

Amphastar Pharmaceuticals, IncBackorder due to increased demand
Hospira, Inc
(Pfizer Subsidiary)
Backorder due to increased demand and possible manufacturing delays

It should be noted that while epinephrine is still generally available in healthcare settings, these shortages bear watching. Epinephrine auto-injectors generally carried by the public are not currently in shortage.

Print or share this article
Click to visit sponsor
Dave Bloom
Dave Bloom
Dave Bloom is CEO and "Blogger in Chief" of SnackSafely.com.

Find Allergy-Friendly Products